Neutral
BioNexus Gene Lab Corp. and Fidelion Diagnostics Announce Landmark Alliance-Touted as a new "DeepSeek Moment" in Precision Oncology
KUALA LUMPUR, Malaysia, July 30, 2025 ( GLOBE NEWSWIRE ) -- BioNexus Gene Lab Corp. ( "BGLC", Nasdaq: BGLC ) and Fidelion Diagnostics Pte Ltd, a Singaporean company ( "Fidelion" ) today announced the signing of a term sheet for a strategic, cross-equity partnership that the parties are calling a ...